FCGR3A and central nervous system cancer: As shown in Figure 1A, mRNA expressions of FCGR3A and FGL2 were significantly upregulated in Low-grade gliomas and glioblastomas respectively compared to normal brain tissue, and there are few mutations in either 2 genes (Figure 1B).